Citrus flavanone glucoside hesperidin acts as a novel CaMKII-δ inhibitor to ameliorate cardiac ischemia/reperfusion Injury | Zendy

AI Assistant Blog Pricing

Open Access

Citrus flavanone glucoside hesperidin acts as a novel CaMKII-δ inhibitor to ameliorate cardiac ischemia/reperfusion Injury

Author(s) -

Wei Zhao,

Hui Zhao

Publication year - 2022

Publication title -

journal of food bioactives

Language(s) - English

Resource type - Journals

eISSN - 2637-8779

pISSN - 2637-8752

DOI - 10.31665/jfb.2022.18311

Subject(s) - medicine , cardiology , ischemia , myocardial infarction , thrombolysis , hesperidin , reperfusion injury , blood flow , anesthesia , pathology , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.